Medindia LOGIN REGISTER
Medindia
Advertisement

Naloxone Nasal Spray Could be Life-Saving in Opioid Overdose

by Rishika Gupta on November 18, 2017 at 2:15 PM
Naloxone Nasal Spray Could be Life-Saving in Opioid Overdose

Concentrated two milligrams of intranasal naloxone spray can deliver the drug as effectively as the 0.4-milligram dose given standardly as intramuscular injection in the first fifteen minutes after opioid overdose found a new study published in Addiction journal.

The 2mg spray also maintains blood levels of naloxone more than twice as high as the 0.4mg IM levels for two hours after administration. It should therefore be highly effective in reversing opioid overdose.

Advertisement


These results support the recent announcement on 14 September 2017 that the European Medicines Agency (EMA) has issued a positive opinion for a 1.8 mg naloxone nasal spray formulation (equivalent to 2mg naloxone hydrochloride), under the brand name Nyxoid.

Take-home naloxone (naloxone kits provided to drug users and other non-medical persons for use in emergency situations) helps to prevent death from heroin/opioid overdose.
Advertisement

Naloxone is usually given by injection, but more user-friendly non-injectable alternatives are being developed, including nasal sprays. To be effective, the intranasal spray must be highly concentrated to achieve good absorption, the dose must be adequate but not excessive, and early absorption should be comparable to IM injection.

This study tested nasal naloxone at 1mg, 2mg, and 4mg doses on 38 healthy volunteers, compared with 0.4mg IM and 0.4mg intravenous doses. Each volunteer received all five study treatments, with one naloxone dose per session and each session separated by a washout period.

Blood plasma concentrations of naloxone were measured nineteen times for each volunteer during each treatment session, with intense sampling in the first 15 minutes after dosing.

All three doses of naloxone nasal spray were well absorbed, with the 2mg spray most closely replicating the performance of the 0.4mg IM naloxone injection over the critical first 15 minutes.

The volunteers experienced no severe adverse effects; the main mild adverse effect was a headache, in six volunteers.

Professor Sir John Strang of King's College London, who co-authored the report, is cautiously optimistic: "Our findings demonstrate good early absorption and overall bioavailability of naloxone in healthy subjects, but concentrated naloxone nasal spray has yet to be formally tested in the target population of opioid users.

Nasal naloxone might be absorbed differently by opioid users due to the damaged nasal mucosa, rhinitis, or nasal obstruction from mucus or vomit during the overdose.

Nevertheless, we are very pleased that concentrated nasal naloxone formulations are now receiving regulatory approval and believe that they will help widen the provision of take-home naloxone and thereby save lives."

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Alcohol & Drug Abuse News

Increasing E-Cigarette Advertising Alarming Youth
Even with advertising regulations in effect across all four nations, most young individuals still reported encountering e-cigarette promotions.
US Drug Overdose Deaths Quadruple from 1999 to 2020
The United States is currently witnessing its highest overall mortality rates in over a century, driven in part by the surge in drug overdose fatalities.
Genes Linked to Psychostimulant Drug Addiction Identified
Deciphering genetic factors in brain responses to METH and COC enables personalized approaches to combat drug abuse.
Insomnia Drug DORA-12 Shows Promise in Preventing Oxycodone Relapse
Giving rats DORA-12 during oxycodone withdrawal reduced future drug-seeking behavior, showing promise for preventing opioid addiction and relapse in humans.
France is All Set to Put a 'Full Stop' to Disposable Vapes
Rising to 9.6% in 2021, daily vaping among New Zealand's 14-year-old students underscores a concerning youth trend.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Naloxone Nasal Spray Could be Life-Saving in Opioid Overdose Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests